In HT-29 and HTC-116 colorectal cancer cells, miR-1 acts as a tumor suppressor, reducing proliferation and migration by targeting the c-MET oncogene (Hepatocyte growth factor receptor) [114], a member of the MAPK pathway [115]. Here, MET is linked to colorectal cancer.